Symbols / CYAN $0.52 +0.00% Cyanotech Corporation

Consumer Defensive • Packaged Foods • United States • OID
CYAN Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Consumer Defensive
Industry Packaged Foods
CEO Mr. Matthew Keith Custer
Exch · Country OID · United States
Market Cap 3.84M
Enterprise Value 15.20M
Income -1.78M
Sales 25.27M
FCF (ttm) -150.00K
Book/sh 1.09
Cash/sh 0.09
Employees 83
Insider 10d —
IPO May 21, 1991
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E —
PEG -7.47
P/S 0.15
P/B 0.48
P/C —
EV/EBITDA 29.50
EV/Sales 0.60
Quick Ratio 0.25
Current Ratio 1.00
Debt/Eq 148.84
LT Debt/Eq —
EPS (ttm) -0.24
EPS next Y —
EPS Growth —
Revenue Growth 19.40%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2005-11-03
Earnings (prior) 2005-11-03
ROA -2.46%
ROE -20.00%
ROIC —
Gross Margin 32.44%
Oper. Margin 2.72%
Profit Margin -7.03%
Shs Outstand 7.39M
Shs Float 4.85M
Insider Own 32.14%
Instit Own 0.00%
Short Float 0.00%
Short Ratio 0.02
Short Interest 177.00
52W High 0.57
vs 52W High -8.77%
52W Low 0.21
vs 52W Low 147.62%
Beta 0.17
Impl. Vol. —
Rel Volume 0.55
Avg Volume 1.56K
Volume 859.00
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom None
Prev Close $0.52
Price $0.52
Change 0.00%
About

Cyanotech Corporation, an agricultural company, engages in the production and sale of natural ingredients and dietary supplement products from microalgae for health and wellness markets. The company offers BioAstin Hawaiian Astaxanthin, a natural antioxidant to enhance skin, and to support eye, joint, brain, and immune health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement to support natural energy, immune system, and cardiovascular health, as well as a source of protein, antioxidant carotenoids, and essential nutrients. It also provides contract extraction, and research and development services. The company sells its products through distributors, retailers, and online channels; direct to consumers; and in bulk form to manufacturers, formulators, and distributors in the health food, cosmetic manufacturers and nutraceuticals, and dietary supplement markets. It operates in the United States, the Asia-Pacific, Europe, and internationally. Cyanotech Corporation was incorporated in 1983 and is headquartered in Kailua-Kona, Hawaii.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$0.52
Latest analyst target
3. DCF / Fair value
$-0.37
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.52
Low
—
High
—
Mean
—
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-08-28 DAVIS MICHAEL A Director and Beneficial Owner of more than 10% of a Class of Security — 50,000 — —
2025-08-28 MULDER DAVID M Director — 50,000 — —
2025-08-28 VIED DAVID L Director — 50,000 — —
2025-07-29 CYSEWSKI GERALD R Officer — 1,577 — —
2025-07-29 JENSEN GLENN D Officer — 1,642 — —
2025-07-29 JOHANSEN JENNIFER M. Officer — 1,380 — —
2025-07-29 NORDIN AMY BETH Officer — 1,502 — —
2025-07-29 CUSTER MATTHEW KEITH Chief Executive Officer — 2,075 — —
2025-04-07 CYSEWSKI GERALD R Officer — 33 — —
2025-04-07 JENSEN GLENN D Officer — 33 — —
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Total Revenue
24.21
+4.96%
23.07
-0.46%
23.18
-35.56%
35.97
Operating Revenue
24.21
+4.96%
23.07
-0.46%
23.18
-35.56%
35.97
Cost Of Revenue
17.34
+1.24%
17.13
+7.58%
15.92
-28.94%
22.40
Reconciled Cost Of Revenue
17.34
+1.24%
17.13
+7.58%
15.92
-28.94%
22.40
Gross Profit
6.88
+15.66%
5.95
-18.10%
7.26
-46.49%
13.57
Operating Expense
9.38
-10.94%
10.54
+3.52%
10.18
-7.40%
10.99
Research And Development
0.45
-34.83%
0.69
-10.52%
0.77
+8.15%
0.71
Selling General And Administration
8.94
-9.27%
9.85
+4.67%
9.41
-8.47%
10.28
Selling And Marketing Expense
4.54
-15.71%
5.38
+13.35%
4.75
-3.32%
4.91
General And Administrative Expense
4.40
-1.50%
4.46
-4.19%
4.66
-13.19%
5.37
Other Gand A
4.40
-1.50%
4.46
-4.19%
4.66
-13.19%
5.37
Total Expenses
26.72
-3.40%
27.66
+6.00%
26.10
-21.85%
33.39
Operating Income
-2.51
+45.38%
-4.59
-57.26%
-2.92
-213.44%
2.57
Total Operating Income As Reported
-2.51
+45.38%
-4.59
-57.26%
-2.92
-213.44%
2.57
EBITDA
-0.63
+74.95%
-2.51
-204.36%
-0.82
-118.35%
4.50
Normalized EBITDA
-0.63
+74.95%
-2.51
-204.36%
-0.82
-118.35%
4.50
Reconciled Depreciation
1.88
-9.71%
2.08
-0.67%
2.10
+9.06%
1.92
EBIT
-2.51
+45.38%
-4.59
-57.26%
-2.92
-213.44%
2.57
Total Unusual Items
—
—
0.00
0.00
Total Unusual Items Excluding Goodwill
—
—
0.00
0.00
Special Income Charges
—
—
0.00
0.00
Net Income
-3.20
+39.19%
-5.27
-53.11%
-3.44
-259.70%
2.15
Pretax Income
-3.19
+39.26%
-5.26
-53.71%
-3.42
-256.83%
2.18
Net Non Operating Interest Income Expense
-0.69
-2.84%
-0.67
-33.07%
-0.50
-28.06%
-0.39
Interest Expense Non Operating
0.69
+2.84%
0.67
+33.07%
0.50
+28.06%
0.39
Net Interest Income
-0.69
-2.84%
-0.67
-33.07%
-0.50
-28.06%
-0.39
Interest Expense
0.69
+2.84%
0.67
+33.07%
0.50
+28.06%
0.39
Tax Provision
0.01
+14.29%
0.01
-61.11%
0.02
-35.71%
0.03
Tax Rate For Calcs
0.00
+0.00%
0.00
+0.00%
0.00
+1536.53%
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-3.20
+39.19%
-5.27
-53.11%
-3.44
-259.70%
2.15
Net Income From Continuing Operation Net Minority Interest
-3.20
+39.19%
-5.27
-53.11%
-3.44
-259.70%
2.15
Net Income From Continuing And Discontinued Operation
-3.20
+39.19%
-5.27
-53.11%
-3.44
-259.70%
2.15
Net Income Continuous Operations
-3.20
+39.19%
-5.27
-53.11%
-3.44
-259.70%
2.15
Normalized Income
-3.20
+39.19%
-5.27
-53.11%
-3.44
-259.70%
2.15
Net Income Common Stockholders
-3.20
+39.19%
-5.27
-53.11%
-3.44
-259.70%
2.15
Diluted EPS
-0.45
+44.44%
-0.81
-47.27%
-0.55
-257.14%
0.35
Basic EPS
-0.45
+44.44%
-0.81
-47.27%
-0.55
-257.14%
0.35
Basic Average Shares
7.07
+8.27%
6.53
+4.60%
6.24
+1.41%
6.16
Diluted Average Shares
7.07
+8.27%
6.53
+4.60%
6.24
+1.23%
6.17
Diluted NI Availto Com Stockholders
-3.20
+39.19%
-5.27
-53.11%
-3.44
-259.70%
2.15
Average Dilution Earnings
—
—
—
0.00
Line Item Trend 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Total Assets
23.49
-6.46%
25.11
-15.53%
29.73
-7.23%
32.05
Current Assets
10.54
-0.43%
10.59
-21.52%
13.50
-17.02%
16.26
Cash Cash Equivalents And Short Term Investments
0.26
-63.65%
0.71
-27.41%
0.97
-62.38%
2.59
Cash And Cash Equivalents
0.26
-63.65%
0.71
-27.41%
0.97
-62.38%
2.59
Cash Financial
0.26
-63.65%
0.71
-27.41%
0.97
-62.38%
2.59
Receivables
1.95
-7.09%
2.10
+57.93%
1.33
-63.67%
3.66
Accounts Receivable
1.95
-7.09%
2.10
+57.93%
1.33
-63.67%
3.66
Gross Accounts Receivable
1.97
-6.81%
2.11
+51.47%
1.40
-62.61%
3.73
Allowance For Doubtful Accounts Receivable
-0.02
-45.45%
-0.01
+82.81%
-0.06
+4.48%
-0.07
Inventory
7.79
+6.50%
7.31
-31.70%
10.71
+13.11%
9.47
Raw Materials
0.91
-37.60%
1.46
-32.28%
2.16
+7.64%
2.00
Work In Process
1.50
-31.75%
2.19
+7.13%
2.05
-28.56%
2.87
Finished Goods
5.38
+47.05%
3.66
-43.74%
6.50
+41.50%
4.59
Prepaid Assets
—
—
—
0.55
Other Current Assets
0.55
+16.63%
0.47
-3.10%
0.48
-11.19%
0.55
Total Non Current Assets
12.95
-10.85%
14.52
-10.54%
16.23
+2.86%
15.78
Net PPE
12.83
-10.87%
14.39
-10.84%
16.14
+3.00%
15.67
Gross PPE
43.98
+0.51%
43.76
+0.68%
43.46
+6.15%
40.94
Accumulated Depreciation
-31.15
-6.08%
-29.36
-7.49%
-27.32
-8.10%
-25.27
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
0.42
+0.00%
0.42
+2.95%
0.41
+3.30%
0.39
Construction In Progress
0.28
+34.12%
0.21
-3.65%
0.22
-74.17%
0.85
Other Properties
28.14
+0.31%
28.05
+0.92%
27.80
+11.41%
24.95
Leases
15.14
+0.42%
15.07
+0.25%
15.04
+1.95%
14.75
Other Non Current Assets
0.12
-9.38%
0.13
+42.22%
0.09
-17.43%
0.11
Total Liabilities Net Minority Interest
14.61
+9.84%
13.30
-0.62%
13.38
+6.55%
12.56
Current Liabilities
10.24
+19.75%
8.55
+5.57%
8.10
+68.08%
4.82
Payables And Accrued Expenses
2.58
+37.88%
1.87
+8.10%
1.73
-48.88%
3.38
Payables
2.22
+54.07%
1.44
+40.94%
1.02
-56.77%
2.36
Accounts Payable
2.22
+54.07%
1.44
+40.94%
1.02
-56.77%
2.36
Current Accrued Expenses
0.36
-16.28%
0.43
-39.27%
0.71
-30.59%
1.02
Pensionand Other Post Retirement Benefit Plans Current
0.35
+8.56%
0.33
-16.79%
0.39
+0.26%
0.39
Current Debt And Capital Lease Obligation
7.20
+16.90%
6.16
+4.55%
5.89
+567.27%
0.88
Current Debt
6.65
+18.05%
5.63
+4.09%
5.41
+1003.88%
0.49
Other Current Borrowings
2.89
-8.09%
3.14
-6.80%
3.37
+587.55%
0.49
Current Capital Lease Obligation
0.56
+4.72%
0.53
+9.73%
0.48
+22.90%
0.39
Current Deferred Liabilities
0.11
-44.44%
0.20
+122.47%
0.09
-45.73%
0.16
Current Deferred Revenue
0.11
-44.44%
0.20
+122.47%
0.09
-45.73%
0.16
Total Non Current Liabilities Net Minority Interest
4.36
-8.03%
4.74
-10.12%
5.28
-31.78%
7.74
Long Term Debt And Capital Lease Obligation
4.36
-8.03%
4.74
-10.07%
5.28
-31.69%
7.72
Long Term Debt
1.00
+0.00%
1.00
+0.00%
1.00
-76.94%
4.34
Long Term Capital Lease Obligation
3.36
-10.18%
3.74
-12.42%
4.28
+26.26%
3.39
Other Non Current Liabilities
—
—
0.00
-80.00%
0.01
Stockholders Equity
8.88
-24.80%
11.81
-27.73%
16.35
-16.11%
19.49
Common Stock Equity
8.88
-24.80%
11.81
-27.73%
16.35
-16.11%
19.49
Capital Stock
0.14
+3.60%
0.14
+11.20%
0.12
+0.81%
0.12
Common Stock
0.14
+3.60%
0.14
+11.20%
0.12
+0.81%
0.12
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
7.20
+3.64%
6.95
+10.77%
6.27
+1.12%
6.20
Ordinary Shares Number
7.20
+3.64%
6.95
+10.77%
6.27
+1.12%
6.20
Additional Paid In Capital
34.84
+0.78%
34.58
+2.13%
33.86
+0.89%
33.56
Retained Earnings
-26.10
-13.99%
-22.90
-29.87%
-17.63
-24.24%
-14.19
Total Equity Gross Minority Interest
8.88
-24.80%
11.81
-27.73%
16.35
-16.11%
19.49
Total Capitalization
9.88
-22.87%
12.81
-26.13%
17.35
-27.18%
23.82
Working Capital
0.30
-85.17%
2.04
-62.23%
5.39
-52.87%
11.44
Invested Capital
16.53
-10.38%
18.44
-18.95%
22.76
-6.40%
24.31
Total Debt
11.56
+6.05%
10.90
-2.36%
11.17
+29.77%
8.61
Net Debt
7.39
+24.75%
5.92
+8.98%
5.43
+142.96%
2.24
Capital Lease Obligations
3.92
-8.33%
4.27
-10.17%
4.76
+25.91%
3.78
Net Tangible Assets
8.88
-24.80%
11.81
-27.73%
16.35
-16.11%
19.49
Tangible Book Value
8.88
-24.80%
11.81
-27.73%
16.35
-16.11%
19.49
Interest Payable
0.02
-31.25%
0.03
+6.67%
0.03
—
Line Of Credit
3.76
+51.00%
2.49
+22.06%
2.04
0.00
Line Item Trend 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Operating Cash Flow
-1.19
-162.20%
-0.46
+78.33%
-2.10
-188.27%
2.38
Cash Flow From Continuing Operating Activities
-1.19
-162.20%
-0.46
+78.33%
-2.10
-188.27%
2.38
Net Income From Continuing Operations
-3.20
+39.19%
-5.27
-53.11%
-3.44
-259.70%
2.15
Depreciation Amortization Depletion
1.88
-9.71%
2.08
-0.67%
2.10
+9.06%
1.92
Depreciation
1.88
-9.71%
2.08
-0.67%
2.10
+9.06%
1.92
Depreciation And Amortization
1.88
-9.71%
2.08
-0.67%
2.10
+9.06%
1.92
Other Non Cash Items
0.03
+292.31%
-0.01
-132.50%
0.04
-29.82%
0.06
Stock Based Compensation
0.25
-31.20%
0.36
+15.81%
0.31
-9.88%
0.34
Provisionand Write Offof Assets
0.01
-77.27%
0.02
-65.63%
0.06
+82.86%
0.04
Asset Impairment Charge
0.01
0.00
-100.00%
0.01
-76.19%
0.02
Change In Working Capital
-0.15
-106.39%
2.36
+301.28%
-1.17
+45.47%
-2.15
Change In Receivables
0.14
+118.16%
-0.79
-134.95%
2.27
+279.65%
-1.26
Changes In Account Receivables
0.14
+118.16%
-0.79
-134.95%
2.27
+279.65%
-1.26
Change In Inventory
-0.47
-113.94%
3.39
+375.71%
-1.23
-71.69%
-0.72
Change In Prepaid Assets
-0.08
-4050.00%
0.00
-96.67%
0.06
+181.08%
-0.07
Change In Payables And Accrued Expense
0.72
+421.01%
0.14
+107.96%
-1.73
-925.24%
0.21
Change In Accrued Expense
-0.00
+99.39%
-0.33
-5.79%
-0.31
-154.75%
0.57
Change In Payable
0.72
+54.39%
0.47
+132.84%
-1.42
-297.21%
-0.36
Change In Account Payable
0.72
+54.39%
0.47
+132.84%
-1.42
-297.21%
-0.36
Change In Other Working Capital
-0.09
-180.73%
0.11
+245.33%
-0.07
-287.50%
0.04
Change In Other Current Liabilities
-0.37
+23.20%
-0.49
-4.96%
-0.46
-32.95%
-0.35
Investing Cash Flow
-0.25
+35.17%
-0.38
+64.33%
-1.07
+15.91%
-1.27
Cash Flow From Continuing Investing Activities
-0.25
+35.17%
-0.38
+64.33%
-1.07
+15.91%
-1.27
Net PPE Purchase And Sale
-0.25
+35.17%
-0.38
+64.33%
-1.07
+15.91%
-1.27
Purchase Of PPE
-0.25
+35.17%
-0.38
+64.33%
-1.07
+15.91%
-1.27
Capital Expenditure
-0.25
+35.17%
-0.38
+64.33%
-1.07
+15.91%
-1.27
Financing Cash Flow
0.99
+73.99%
0.57
-63.36%
1.55
+167.91%
-2.29
Cash Flow From Continuing Financing Activities
0.99
+73.99%
0.57
-63.36%
1.55
+167.91%
-2.29
Net Issuance Payments Of Debt
1.00
+380.38%
0.21
-86.63%
1.56
+169.93%
-2.23
Issuance Of Debt
1.75
+70.73%
1.02
-62.04%
2.70
0.00
Repayment Of Debt
-0.75
+8.58%
-0.82
+28.23%
-1.14
+49.13%
-2.23
Long Term Debt Issuance
—
—
0.00
0.00
Long Term Debt Payments
-0.27
-10.37%
-0.24
+49.48%
-0.48
+61.38%
-1.24
Net Long Term Debt Issuance
-0.27
-10.37%
-0.24
+49.48%
-0.48
+61.38%
-1.24
Short Term Debt Issuance
1.75
+70.73%
1.02
-62.04%
2.70
0.00
Short Term Debt Payments
-0.48
+16.52%
-0.57
+12.88%
-0.66
+34.00%
-1.00
Net Short Term Debt Issuance
1.27
+182.22%
0.45
-77.94%
2.04
+304.00%
-1.00
Net Common Stock Issuance
0.00
-100.00%
0.39
0.00
0.00
Net Other Financing Charges
-0.01
+50.00%
-0.03
-180.00%
-0.01
+80.77%
-0.05
Changes In Cash
-0.45
-68.54%
-0.27
+83.47%
-1.61
-37.10%
-1.18
Beginning Cash Position
0.71
-27.41%
0.97
-62.38%
2.59
-31.27%
3.77
End Cash Position
0.26
-63.65%
0.71
-27.41%
0.97
-62.38%
2.59
Free Cash Flow
-1.44
-72.25%
-0.84
+73.61%
-3.17
-385.66%
1.11
Interest Paid Supplemental Data
0.63
+8.06%
0.58
+42.89%
0.41
+19.30%
0.34
Income Tax Paid Supplemental Data
0.01
+33.33%
0.01
-81.25%
0.03
+1500.00%
0.00
Common Stock Issuance
0.00
-100.00%
0.39
0.00
0.00
Issuance Of Capital Stock
0.00
-100.00%
0.39
0.00
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category